The Harvard Medical School Family Health Guide

Harvard Health Publications
Order the Book
Contact Us
Sign up for our free e-mail newsletter, HEALTHbeat.  
Email Address:
 
First Name (optional):
 
 
Special Health Information Reports
Incontinence
Weight Loss
Prostate Disease
Vitamins and Minerals
Aching Hands
See All Titles
Browse Health Information
Common Medical Conditions
Wellness & Prevention
Emotional Well Being & Mental Health
Women’s Health
Men’s Health
Heart & Circulatory Health
About the Book
New Information
About the Team
Order the Book
Return to the Family Health Guide Home Page
  Harvard Health Publications
contact us



Observing JUPITER

A trial dubbed JUPITER made a big splash at the American Heart Association meeting in November 2008. On the surface, its results support wider use of statin drugs among people with normal cholesterol levels and more widespread testing for C-reactive protein (CRP). But, there’s more to the story.

Exploring the details

JUPITER included nearly 18,000 volunteers at prime heart attack ages — men ages 50 and older, women 60 and older. None had high cholesterol. In fact, the average LDL was just over 100 mg/dL, a level most doctors would congratulate their healthy patients for achieving. None had ever been diagnosed with heart disease, either, though a fair number were smokers, or overweight, or had high blood pressure. The one “metabolic fault” shared by all of the volunteers was a high CRP. This protein reflects the amount of inflammation in the body, some of it generated by atherosclerosis (plaque buildup in the inner lining of an artery).

The volunteers who took 20 mg of Crestor, a powerful statin, every day for nearly two years did better than those taking a placebo. Their average LDL plummeted from 108 mg/dL to 55 (that’s less than half of what is considered normal), while the average LDL in the placebo group hovered around 108. More important, the statin group had about 50% fewer heart attacks and strokes than the placebo group. Although that reduction sounds really impressive, in absolute terms it represents a reduction from 1.5% of participants in the placebo group to 0.7% in the Crestor group. Side effects like muscle pain were the same in both groups.

Interpreting JUPITER

The trial’s most important message is that many factors — not just high cholesterol — can identify individuals most likely to benefit from a statin and other risk-reducing strategies.

There’s no question that we need new ways to identify people with hidden heart disease. Is CRP a “new way”? It makes the most sense for individuals at intermediate risk of heart disease. In this group, CRP information might tip the balance to, or from, starting statin therapy. The test isn’t needed in people at high risk, most of whom should be taking a statin anyway, and we still don’t know about its value in people at low risk.

Most older Americans have some artery-threatening plaque. If statins cost pennies a day and were 100% safe, then it might be a good idea for all adults to take one to stabilize their plaque. But statins cost real money — a year’s supply of Crestor or another name-brand statin can top $1,200. They can cause aches and pains and, in rare cases, can damage muscle. They’ve also been linked to memory loss, though this, too, is uncommon.

In people with heart disease or at high risk for it, taking a statin makes sense, even when LDL is in the normal range. JUPITER provides clues as to which seemingly healthy individuals might also benefit from a statin: those with high CRP. Stay tuned — new guidelines are sure to follow.

February 2009

Help prevent coronary artery disease with this heart health report
Click to enlarge

Beating Heart Disease

If you follow the news about heart disease closely, it’s easy to be overwhelmed or confused about what puts you at risk and how you can protect yourself. This report helps you identify the risk factors you can control, which range from medical conditions such as high blood pressure to lifestyle choices such as an unhealthy diet or lack of exercise. Read more

Back to Previous Page




©2000–2006 President & Fellows of Harvard College
Sign Up Now For
HEALTHbeat
Our FREE E-mail Newsletter

In each weekly issue of HEALTHbeat:

  • Get trusted advice from the doctors at Harvard Medical School
  • Learn tips for living a healthy lifestyle
  • Stay up-to-date on the latest developments in health
  • Plus, receive your FREE Bonus Report, Living to 100: What's the secret?

[ Maybe Later ] [ No Thanks ]